Selected Publications
Mevel R, Steiner I, Mason S, Galbraith LC, Patel R, Fadlullah MZ, Ahmad I, Leung HY, Oliveira P, Blyth K, Baena E, Lacaud G. (2020)
RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.
Elife 9:e60225. PubMed abstract
Murphy RG, Roddy AC, Srivastava S, Baena E, Waugh DJ, M O'Sullivan J, McArt DG, Jain S, LaBonte MJ. (2020)
Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods.
NAR Genom Bioinform. 2(3):lqaa062. PubMed abstract
Parry MA, Srivastava S, Ali A, Cannistraci A, Antonello J, Barros-Silva JD, Ubertini V, Ramani V, Lau M, Shanks J, Nonaka D, Oliveira P, Hambrock T, Leong HS, Dhomen N, Miller C, Brady G, Dive C, Clarke NW, Marais R, Baena E. (2019)
Genomic evaluation of multiparametric magnetic resonance imaging-visible and -nonvisible lesions in clinically localised prostate cancer.
European Urology Oncology 2(1):1-11. PubMed abstract
Barros-Silva JD, Linn DE, Steiner I, Guo G, Ali A, Pakula H, Ashton G, Peset I, Brown M, Clarke NW, Bronson RT, Yuan GC, Orkin SH, Li Z, Baena E. (2018)
Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer.
Cell Reports 25(12):3504-3518. PubMed abstract
Wang P, Dreger M, Madrazo E, Williams CJ, Samaniego R, Hodson NW, Monroy F, Baena E, Sánchez-Mateos P, Hurlstone A, Redondo-Muñoz J. (2018)
WDR5 modulates cell motility and morphology and controls nuclear changes induced by a 3D environment.
Proc Natl Acad Sci U S A [Epub 9 July] PubMed abstract
Ali A, Hoyle A, Baena E, Clarke NW. (2017)
Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.
Current Opinion in Urology 27(3):217-224. PubMed abstract
Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J, Nguyen M, Zhang X, Godinho FJ, Bronson RT, Mucci LA, Loda M, Yuan GC, Orkin SH, Li Z. (2013)
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Genes & Development 27(6):683-98. PubMed abstract
Vallespinós M, Fernández D, Rodríguez L, Alvaro-Blanco J, Baena E, Ortiz M, Dukovska D, Martínez D, Rojas A, Campanero MR, Moreno de Alborán I. (2011)
B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.
Journal of Immunology 186(12):6726-36. PubMed abstract
Baena E, Ortiz M, Martínez-A C, de Alborán IM. (2007)
c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(-)Sca-1(+)c-Kit(-) cell generation through p21.
Experimental Hematology 35(9):1333-43. PubMed abstract
Baena E, Gandarillas A, Vallespinós M, Zanet J, Bachs O, Redondo C, Fabregat I, Martinez-A C, de Alborán IM.(2005)
c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver.
Proc Natl Acad Sci U S A 102(20):7286-91. PubMed abstract